While a clear efficacy of the DAG-binding competitor calphostin-C was evident, single inhibition of AKT was not sufficient to cause death in CRC-SC lines, reinforcing the concept that CSC survival and/or proliferation is driven by concomitant activation of multiple pathways. The gene discussed is AKT1; the disease is colorectal carcinoma.